3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
6
Melanoma
5
Glioblastoma
5
Lymphoma
4
Breast Neoplasms
4
Recurrence
3
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioma
3
Carcinoma, Ovarian Epithelial
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Neuroblastoma
2
Neoplasms
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Brain Neoplasms
2
Advanced Malignant Solid Tumor
2
Xanthomatosis, Cerebrotendinous
1
Wilms Tumor
1
Vaccinia
1
Interventions
Temozolomide
27
Irinotecan
8
Filgrastim
8
Carmustine
7
Carboplatin
7
Surgical Procedures, Operative
6
O(6)-benzylguanine
6
Flucytosine
6
sargramostim
4
Vorinostat
4
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
4
vocimagene amiretrorepvec
3
lonafarnib
3
Radiosurgery
3
Lenalidomide
3
Imatinib Mesylate
3
Genetic Therapy
3
Erlotinib Hydrochloride
3
Cyclophosphamide
3
Bortezomib
3
temsirolimus
2
cediranib
2
aldesleukin
2
Vincristine
2
Vinblastine
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiation
2
Peripheral Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Oligodendroglioma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled